Scientific Sessions

Rapid advancements in pharmaceutics and drug delivery technologies are redefining the development, manufacturing, and clinical performance of modern therapeutics. This session provides a comprehensive platform to showcase cutting-edge innovations across formulation science, drug delivery systems, and enabling technologies. Key topics include advanced dosage forms, nanotechnology-enabled delivery, targeted and precision therapeutics, controlled and sustained release systems, smart and stimuli-responsive platforms, biologic and nucleic acid delivery, and patient-centric formulation design. Discussions will also address digital pharmaceutics, data-driven development, regulatory science, and translational pathways that accelerate innovation from laboratory research to clinical and commercial success. Emphasis will be placed on interdisciplinary approaches and real-world case studies that highlight how emerging technologies are improving therapeutic efficacy, safety, and patient outcomes.

We invite pharmaceutical scientists, formulation and process development experts, biomedical engineers, clinicians, regulatory professionals, and industry leaders to submit one-page abstracts for presentation at the International Conference on Pharmaceutics & Innovative Drug Delivery Systems (Pharmaceutics 2027). Join us to exchange knowledge, engage with global experts, and contribute to shaping the future of pharmaceutics and drug delivery technologies.

Novel drug delivery systems and controlled release strategies are reshaping modern pharmaceutics by enabling precise modulation of drug release, improved therapeutic efficacy, and enhanced patient compliance. This session focuses on innovative delivery platforms and formulation approaches that provide temporal and spatial control over drug release. Key topics include advanced polymeric and lipid-based systems, implantable and injectable depots, micro- and nanoscale carriers, stimuli-responsive platforms, and hybrid delivery technologies. Discussions will also address pharmacokinetic and pharmacodynamic optimization, modeling and simulation, scalability, manufacturing challenges, and regulatory considerations. Emphasis will be placed on translational research and clinical relevance, highlighting how novel controlled release strategies can improve safety, reduce dosing frequency, and support next-generation therapeutics.

We invite pharmaceutical scientists, formulation experts, materials scientists, pharmacokineticists, biomedical engineers, and industry professionals to submit one-page abstracts for presentation at the International Conference on Pharmaceutics & Innovative Drug Delivery Systems (Pharmaceutics 2027). Join us to share innovative research, engage with global experts, and contribute to advancing novel drug delivery and controlled release technologies.

Nanotechnology-based drug delivery systems are transforming therapeutic design by enabling precise targeting, improved bioavailability, and controlled drug release at the molecular and cellular levels. This session focuses on the development and application of nanoscale delivery platforms for targeted therapeutics. Key topics include polymeric and lipid-based nanoparticles, nanocrystals, dendrimers, inorganic and hybrid nanomaterials, surface functionalization for targeting, and stimuli-responsive nanosystems. Discussions will address nano–bio interactions, pharmacokinetics, safety and toxicity considerations, scalability, and regulatory challenges. Emphasis will be placed on translational research and clinical case studies demonstrating how nanotechnology-driven approaches enhance therapeutic efficacy, reduce off-target effects, and advance precision medicine.

We invite pharmaceutical scientists, nanotechnologists, formulation experts, materials scientists, biomedical engineers, and industry professionals to submit one-page abstracts for presentation at the International Conference on Pharmaceutics & Innovative Drug Delivery Systems (Pharmaceutics 2027). Join us to share cutting-edge research, engage with global experts, and contribute to advancing nanotechnology-enabled targeted therapeutics.

Pharmaceutical formulation development is a critical step in transforming active pharmaceutical ingredients into safe, effective, and patient-acceptable dosage forms. This session focuses on systematic and innovative approaches to formulation design and optimization across the drug development lifecycle. Key topics include preformulation studies, excipient selection, dosage form design, optimization using design of experiments (DoE), Quality by Design (QbD) principles, and formulation troubleshooting. Discussions will also address scale-up and manufacturing considerations, stability enhancement, bioavailability optimization, and regulatory expectations. Emphasis will be placed on data-driven and translational strategies that integrate scientific understanding with practical development to ensure robust, reproducible, and high-quality pharmaceutical products.

We invite pharmaceutical scientists, formulation experts, process development specialists, quality professionals, and industry practitioners to submit one-page abstracts for presentation. Join us to share insights, exchange knowledge with global experts, and contribute to advancing pharmaceutical formulation development and optimization strategies.

Biopharmaceutics plays a central role in understanding how drug properties, formulation design, and physiological factors influence absorption, distribution, and overall therapeutic performance. This session focuses on fundamental and applied aspects of drug absorption and distribution, integrating biopharmaceutical principles with modern experimental and modeling approaches. Key topics include permeability and transport mechanisms, dissolution and solubility behavior, tissue distribution, transporter and enzyme interactions, pharmacokinetic modeling, and in vitro–in vivo correlations. Discussions will also address formulation strategies to optimize absorption, predictive tools for drug disposition, and translational studies supporting rational drug development and regulatory decision-making. Emphasis will be placed on bridging mechanistic understanding with clinical relevance to improve drug efficacy, safety, and performance.

We invite pharmaceutical scientists, biopharmaceutics researchers, pharmacokineticists, formulation experts, and industry professionals to submit one-page abstracts for presentation. Join us to share research, engage with global experts, and contribute to advancing biopharmaceutics and drug absorption and distribution science.

Oral drug delivery remains the most widely used and patient-preferred route of administration, yet it presents significant challenges related to drug solubility, stability, permeability, and site-specific absorption within the gastrointestinal tract. This session focuses on advanced oral drug delivery systems and innovative strategies for gastrointestinal targeting. Key topics include modified-release oral dosage forms, gastroretentive systems, enteric and colon-targeted delivery, lipid-based and polymeric carriers, permeability enhancement, and microbiome-responsive formulations. Discussions will also address formulation design, in vitro–in vivo correlations, pharmacokinetic optimization, patient adherence, and regulatory considerations. Emphasis will be placed on translational research and clinical relevance, highlighting novel oral delivery technologies that enhance bioavailability, therapeutic efficacy, and targeted gastrointestinal therapy.

We invite pharmaceutical scientists, formulation experts, biopharmaceutical researchers, pharmacokineticists, and industry professionals to submit one-page abstracts for presentation at the International Conference on Pharmaceutics & Innovative Drug Delivery Systems. Join us to share research, engage with global experts, and contribute to advancing oral drug delivery and gastrointestinal targeting strategies.

Parenteral and injectable drug delivery systems remain critical for the administration of biologics, vaccines, and therapies requiring rapid or precise systemic exposure. This session focuses on advanced formulation and delivery innovations designed to improve the safety, efficacy, and patient experience of injectable therapies. Key topics include long-acting injectables, depot formulations, nanosuspensions, injectable implants, in situ forming systems, and combination product design. Discussions will also address formulation stability, sterility assurance, device–drug compatibility, administration technologies, patient-centric design, and regulatory considerations. Emphasis will be placed on translational research and scalable manufacturing strategies that enable the successful clinical adoption of next-generation parenteral and injectable drug delivery platforms.

We invite pharmaceutical scientists, formulation experts, biomedical engineers, clinicians, device developers, and industry professionals to submit one-page abstracts for presentation at the International Conference on Pharmaceutics & Innovative Drug Delivery Systems (Pharmaceutics 2027). Join us to share innovative research, engage with global experts, and contribute to advancing parenteral and injectable drug delivery technologies.

Transdermal, topical, and mucosal drug delivery systems provide effective, patient-friendly alternatives to conventional administration routes, enabling localized and systemic therapy with improved safety and compliance. This session focuses on advanced formulation strategies and delivery technologies designed to overcome biological barriers such as the skin and mucosal membranes. Key topics include transdermal patches, topical creams and gels, microneedles, iontophoresis, penetration enhancers, buccal and sublingual delivery systems, vaginal and rectal formulations, and bioadhesive platforms. Discussions will also address formulation design, permeation mechanisms, stability, patient adherence, and regulatory considerations. Emphasis will be placed on translational research and clinical relevance, highlighting innovative approaches that enhance drug absorption, therapeutic efficacy, and patient-centered care.

We invite pharmaceutical scientists, formulation experts, dermatological and mucosal researchers, biomedical engineers, clinicians, and industry professionals to submit one-page abstracts for presentation at the International Conference on Pharmaceutics & Innovative Drug Delivery Systems (Pharmaceutics 2027). Join us to share research, exchange ideas with global experts, and contribute to advancing transdermal, topical, and mucosal drug delivery technologies.

Pulmonary and nasal drug delivery systems offer non-invasive and highly effective routes for both local and systemic therapy, providing rapid onset of action and improved patient compliance. This session focuses on advanced formulation and device-based technologies for drug delivery via the respiratory and nasal pathways. Key topics include dry powder inhalers, metered-dose inhalers, nebulization systems, nasal sprays, powders, and gels, as well as formulation strategies for small molecules, biologics, vaccines, and gene-based therapies. Discussions will also address aerosol science, particle engineering, device–formulation compatibility, deposition and absorption mechanisms, safety considerations, and regulatory requirements. Emphasis will be placed on translational research and clinical relevance, highlighting innovations that enhance delivery efficiency, therapeutic outcomes, and patient-centered respiratory and nasal therapies.

We invite pharmaceutical scientists, formulation experts, aerosol scientists, biomedical engineers, clinicians, and industry professionals to submit one-page abstracts for presentation at the International Conference on Pharmaceutics & Innovative Drug Delivery Systems (Pharmaceutics 2027). Join us to share research, engage with global experts, and contribute to advancing pulmonary and nasal drug delivery technologies.

Ocular drug delivery presents unique formulation and physiological challenges due to complex eye anatomy, rapid drug clearance, and stringent safety requirements. This session focuses on advanced ocular drug delivery systems and innovative ophthalmic formulations designed to improve drug residence time, bioavailability, and therapeutic efficacy. Key topics include topical, intraocular, and periocular delivery systems; in situ gelling formulations; nanoparticles and liposomes for ocular use; sustained-release implants; and permeation-enhancing strategies. Discussions will also address formulation stability, sterilization, patient compliance, regulatory considerations, and translational challenges in ophthalmic product development. Emphasis will be placed on bridging formulation science with clinical needs to advance safe, effective, and patient-friendly ocular therapies.

We invite pharmaceutical scientists, formulation experts, ophthalmic researchers, biomedical engineers, clinicians, and industry professionals to submit one-page abstracts for presentation at the International Conference on Pharmaceutics & Innovative Drug Delivery Systems (Pharmaceutics 2027). Join us to share research, exchange insights with global experts, and contribute to advancing ocular drug delivery and ophthalmic formulation science.

Targeted drug delivery and precision therapeutic strategies are redefining modern pharmaceutics by enabling site-specific treatment with enhanced efficacy and reduced systemic toxicity. This session focuses on advanced delivery platforms designed to selectively deliver therapeutics to specific cells, tissues, or disease sites. Key topics include ligand- and receptor-mediated targeting, antibody–drug conjugates, nanoparticle-based targeting systems, stimuli-guided precision delivery, and combination therapeutic strategies. Discussions will also cover patient stratification, biomarker-driven targeting, pharmacokinetic optimization, and translational challenges from bench to bedside. Emphasis will be placed on integrating formulation science, molecular targeting, and clinical insights to advance precision medicine and improve patient outcomes.

We invite pharmaceutical scientists, formulation experts, molecular biologists, biomedical engineers, clinicians, and industry professionals to submit one-page abstracts for presentation at the International Conference on Pharmaceutics & Innovative Drug Delivery Systems (Pharmaceutics 2027). Join us to share innovative research, engage with global experts, and contribute to advancing targeted and precision-based therapeutic approaches.

Smart drug delivery systems and stimuli-responsive materials represent a transformative advancement in pharmaceutics, enabling precise, controlled, and site-specific therapeutic action. This session focuses on innovative delivery platforms that respond to internal physiological cues and external triggers such as pH, temperature, enzymes, redox gradients, light, magnetic fields, and ultrasound. Key topics include smart polymers, responsive hydrogels, bioresponsive nanocarriers, on-demand release systems, and feedback-controlled delivery devices. Discussions will also address material design principles, drug–carrier interactions, biocompatibility, safety, scalability, and regulatory considerations. Emphasis will be placed on translational research and clinical relevance, highlighting how intelligent and adaptive delivery systems can improve therapeutic efficacy, minimize side effects, and support personalized and precision medicine.

We invite pharmaceutical scientists, materials scientists, formulation experts, biomedical engineers, nanotechnologists, and industry professionals to submit one-page abstracts for presentation at the International Conference on Pharmaceutics & Innovative Drug Delivery Systems (Pharmaceutics 2027). Join us to share cutting-edge research, engage with global experts, and contribute to advancing next-generation smart and responsive drug delivery technologies.

Nanotechnology-driven drug delivery systems have revolutionized pharmaceutics by enabling precise targeting, enhanced bioavailability, and controlled therapeutic release. This session focuses on the design, development, and application of pharmaceutical nanocarriers and next-generation delivery vehicles. Topics include polymeric and lipid-based nanoparticles, dendrimers, micelles, inorganic nanocarriers, hybrid systems, and stimuli-responsive delivery platforms. Discussions will address physicochemical characterization, drug loading and release mechanisms, biological interactions, safety and toxicity considerations, and clinical translation challenges. Emphasis will be placed on translational research, scalability, and regulatory pathways that support the successful integration of advanced nanocarriers into real-world therapeutic applications.

We invite pharmaceutical scientists, nanotechnologists, formulation experts, materials scientists, biomedical engineers, and industry professionals to submit one-page abstracts for presentation at the International Conference on Pharmaceutics & Innovative Drug Delivery Systems (Pharmaceutics 2027). Join us to share cutting-edge research, engage with global experts, and contribute to advancing nanocarrier-based and advanced drug delivery technologies.

Lipid-based drug delivery systems have emerged as powerful platforms for enhancing drug solubility, stability, and targeted delivery across a wide range of therapeutic applications. This session focuses on advances in lipid-based formulations, including liposomes, solid lipid nanoparticles, nanostructured lipid carriers, self-emulsifying drug delivery systems (SEDDS), and lipid-based injectables. Key topics include formulation design, characterization, scalability, stability, and regulatory considerations. Discussions will also explore targeted and stimuli-responsive lipid systems, combination therapies, and clinical translation of liposomal products. Emphasis will be placed on bridging formulation science with industrial manufacturing and clinical performance to improve therapeutic efficacy and patient outcomes.

We invite pharmaceutical scientists, formulation experts, lipid chemists, nanotechnologists, pharmaco kineticists, and industry professionals to submit one-page abstracts for presentation at the International Conference on Pharmaceutics & Innovative Drug Delivery Systems (Pharmaceutics 2027). Join us to share research, exchange insights with global experts, and advance the development of lipid-based and liposomal drug delivery technologies.

Polymer-based drug delivery systems and biodegradable carriers have become central to the development of advanced therapeutics, offering controlled release, targeted delivery, and improved biocompatibility. This session focuses on the design, synthesis, and application of natural and synthetic polymers for drug delivery, including biodegradable and bioresorbable materials. Key topics include polymeric nanoparticles and micelles, hydrogels, microspheres, stimuli-responsive systems, and polymer–drug conjugates. Discussions will also address degradation kinetics, safety and toxicity considerations, scale-up and manufacturing challenges, and regulatory perspectives. Emphasis will be placed on translational research that bridges materials science with pharmaceutical applications, enabling safer, more effective, and sustainable drug delivery solutions.

We invite pharmaceutical scientists, polymer chemists, formulation experts, materials scientists, biomedical engineers, and industry professionals to submit one-page abstracts for presentation at the International Conference on Pharmaceutics & Innovative Drug Delivery Systems (Pharmaceutics 2027). Join us to share research, collaborate with global experts, and contribute to advancing polymer-based and biodegradable drug delivery technologies.

Poor aqueous solubility and limited bioavailability remain major challenges in the development of many modern pharmaceutical compounds. This session focuses on innovative formulation and delivery strategies aimed at enhancing drug solubility, dissolution rate, and systemic availability. Key topics include solid dispersions, particle size reduction technologies, lipid-based delivery systems, nanocrystals, cyclodextrin inclusion complexes, co-crystals, and amorphous formulations. Discussions will also address in vitro–in vivo relationships, formulation selection, scale-up considerations, and regulatory perspectives. Emphasis will be placed on translational research and case studies demonstrating successful approaches to improving oral and non-oral bioavailability, ultimately leading to safer, more effective therapeutic products.

We invite pharmaceutical scientists, formulation experts, physical chemists, pharmacokineticists, and industry professionals to submit one-page abstracts for presentation at the International Conference on Pharmaceutics & Innovative Drug Delivery Systems (Pharmaceutics 2027). Join us to share research, engage with global experts, and contribute to advancing solubility enhancement and bioavailability optimization in pharmaceutical development.

Controlled, sustained, and extended drug delivery systems play a vital role in optimizing therapeutic efficacy, reducing dosing frequency, and improving patient adherence. This session focuses on advanced formulation strategies and delivery technologies designed to achieve precise control over drug release profiles. Key topics include polymer-based systems, matrix and reservoir designs, osmotic and stimulus-responsive delivery platforms, implantable and injectable systems, and long-acting formulations. Discussions will also cover pharmacokinetic optimization, modeling and simulation approaches, scale-up challenges, and regulatory considerations. Emphasis will be placed on translational research that bridges formulation science with clinical performance, highlighting innovations that enhance safety, efficacy, and patient convenience across a wide range of therapeutic applications.

We invite pharmaceutical scientists, formulation experts, materials scientists, pharmacokineticists, and industry professionals to submit one-page abstracts for presentation at the International Conference on Pharmaceutics & Innovative Drug Delivery Systems (Pharmaceutics 2027). Join us to share research, exchange ideas with global experts, and contribute to the advancement of next-generation controlled and long-acting drug delivery systems.

Biologic drugs, including proteins, peptides, and monoclonal antibodies, represent a rapidly expanding class of therapeutics with high specificity and efficacy. This session focuses on innovative strategies for the formulation, stabilization, and delivery of biologics, addressing challenges such as protein degradation, immunogenicity, and targeted delivery. Topics include controlled-release systems, nanocarriers, conjugation technologies, advanced excipients, and regulatory considerations for biologics. Discussions will also explore translational research bridging lab-scale innovations with scalable production, ensuring safety, efficacy, and patient accessibility. Emphasis will be placed on integrating formulation science with emerging delivery technologies to enhance therapeutic outcomes and support personalized medicine approaches.

We invite pharmaceutical scientists, formulation experts, biotechnologists, biomedical engineers, and industry professionals to submit one-page abstracts for presentation at the International Conference on Pharmaceutics & Innovative Drug Delivery Systems (Pharmaceutics 2027). Join us to share research, engage with global experts, and contribute to advancing biologic drug development and delivery innovations.

The advent of gene and nucleic acid-based therapeutics has transformed modern medicine, offering treatments for previously untreatable diseases. This session focuses on the design, formulation, and delivery strategies for DNA, RNA, and other nucleic acid therapeutics. Topics include lipid nanoparticles, polymeric carriers, viral and non-viral vectors, CRISPR-based delivery systems, stability optimization, targeted tissue delivery, and immunogenicity mitigation. Discussions will also cover translational challenges, scalability, regulatory considerations, and emerging technologies that enhance the safety, efficacy, and precision of nucleic acid therapies. Emphasis will be placed on bridging laboratory research with clinical applications to accelerate therapeutic development and improve patient outcomes.

We invite pharmaceutical scientists, molecular biologists, formulation experts, biomedical engineers, and industry professionals to submit one-page abstracts for presentation at the International Conference on Pharmaceutics & Innovative Drug Delivery Systems (Pharmaceutics 2027). Join us to share research, collaborate with global leaders, and advance the field of nucleic acid therapeutics and delivery technologies.

The development of effective vaccines relies not only on immunogenic components but also on advanced formulation and delivery strategies that maximize stability, efficacy, and patient accessibility. This session focuses on cutting-edge approaches in vaccine formulation and delivery, including novel adjuvants, nanoparticle-based carriers, lipid and polymeric systems, mucosal delivery, and cold-chain-independent technologies. Topics also include controlled-release platforms, targeted immunization strategies, and regulatory considerations for accelerated vaccine development. Emphasis will be placed on translational research bridging laboratory innovations with scalable production and real-world immunization programs. Discussions will highlight solutions that enhance global vaccine accessibility, improve immunogenicity, and support rapid responses to emerging infectious diseases.

We invite pharmaceutical scientists, immunologists, formulation experts, biomedical engineers, and industry practitioners to submit one-page abstracts for presentation at the International Conference on Pharmaceutics & Innovative Drug Delivery Systems (Pharmaceutics 2027). Join us to share research, exchange ideas with global experts, and contribute to the advancement of next-generation vaccines and delivery technologies.

Ensuring the stability and longevity of pharmaceutical products is critical for maintaining efficacy, safety, and patient compliance. This session focuses on strategies for enhancing drug stability, optimizing packaging, and extending shelf life under diverse storage and environmental conditions. Key topics include physicochemical and microbiological stability, stress testing, formulation strategies for stability improvement, advanced packaging materials, controlled-release systems, and regulatory considerations. Discussions will also cover predictive modeling, stability-indicating assays, and innovations in packaging design to protect products from temperature, light, moisture, and mechanical stress. Emphasis will be placed on integrating scientific research, industry best practices, and regulatory requirements to ensure product quality throughout its lifecycle.

We invite pharmaceutical scientists, formulation specialists, packaging engineers, quality assurance professionals, and regulatory experts to submit one-page abstracts for presentation at the International Conference on Pharmaceutics & Innovative Drug Delivery Systems (Pharmaceutics 2027). Join us to share research, explore innovative strategies, and contribute to enhancing drug stability, packaging, and shelf-life in modern pharmaceutical practice.

Quality by Design (QbD) is a systematic, science- and risk-based approach that ensures pharmaceutical products meet predefined quality, safety, and efficacy standards from development through commercial manufacturing. This session focuses on integrating QbD principles into drug development, formulation design, and process optimization. Key topics include critical quality attributes (CQAs), critical process parameters (CPPs), risk assessment, design of experiments (DoE), process analytical technology (PAT), and regulatory expectations. Discussions will highlight case studies demonstrating how QbD enhances product robustness, reduces variability, and accelerates regulatory approval. Emphasis will also be placed on linking QbD with continuous manufacturing, digital tools, and data-driven decision-making to achieve efficient, reproducible, and compliant pharmaceutical development.

We invite pharmaceutical scientists, formulation experts, process engineers, quality assurance professionals, and regulatory specialists to submit one-page abstracts for presentation at the International Conference on Pharmaceutics & Innovative Drug Delivery Systems (Pharmaceutics 2027). Join us to share insights, engage with global leaders, and advance the implementation of QbD in modern pharmaceutical development.

Ensuring that pharmaceutical products meet stringent regulatory standards is critical for patient safety, product quality, and market approval. This session focuses on the evolving landscape of regulatory frameworks, safety assessments, and compliance strategies in the pharmaceutical industry. Topics include global regulatory requirements, good manufacturing practices (GMP), pharmacovigilance, quality assurance systems, risk management, and emerging regulatory considerations for innovative drug delivery platforms. Discussions will also address regulatory challenges in advanced formulations, biologics, continuous manufacturing, and personalized medicine. Emphasis will be placed on aligning scientific innovation with compliance, minimizing regulatory risks, and ensuring safe, effective, and high-quality medicines reach patients worldwide.

We invite regulatory scientists, quality assurance professionals, pharmacologists, formulation experts, and industry practitioners to submit one-page abstracts for presentation at the International Conference on Pharmaceutics & Innovative Drug Delivery Systems (Pharmaceutics 2027). Join us to exchange insights, engage with global experts, and contribute to strengthening regulatory compliance and patient safety in pharmaceutical practice.

The shift toward patient-centered healthcare is transforming drug development, with an emphasis on therapies tailored to individual needs, lifestyles, and genetic profiles. This session explores innovative drug delivery systems designed to enhance therapeutic outcomes, improve adherence, and minimize side effects. Topics include personalized formulations, targeted delivery technologies, wearable and smart drug delivery devices, pharmacogenomics-guided therapy, and patient-focused design principles. Discussions will cover advances in nanomedicine, controlled-release systems, and digital health integration to monitor and optimize treatment. Case studies highlighting real-world applications of personalized medicine and patient-centric strategies will illustrate the impact of these innovations on efficacy, safety, and quality of life.

We invite pharmaceutical scientists, clinicians, formulation experts, biomedical engineers, and healthcare innovators to submit one-page abstracts for presentation at the International Conference on Pharmaceutics & Innovative Drug Delivery Systems (Pharmaceutics 2027). Join us to share research, collaborate with global leaders, and contribute to the evolution of precision and patient-focused therapeutics.

Understanding the relationship between in vitro drug performance and in vivo pharmacokinetics is critical for efficient drug development, regulatory approval, and therapeutic consistency. This session focuses on the principles, methodologies, and applications of in vitro–in vivo correlation (IVIVC) and bioequivalence studies. Topics include predictive modeling of drug release and absorption, pharmacokinetic and pharmacodynamic analysis, formulation optimization, and regulatory requirements for generic and innovator drugs. Emphasis will be placed on modern analytical techniques, modeling and simulation approaches, quality by design (QbD) frameworks, and case studies demonstrating successful IVIVC applications. Discussions will also explore challenges in establishing bioequivalence for complex formulations, extended-release systems, and biologics, highlighting strategies to improve translational predictability and accelerate product development.

We invite pharmaceutical scientists, formulation specialists, pharmacokineticists, regulatory experts, and industry professionals to submit one-page abstracts for presentation at the International Conference on Pharmaceutics & Innovative Drug Delivery Systems (Pharmaceutics 2027). Join us to share research, engage with global experts, and advance the science and practice of IVIVC and bioequivalence studies.

Innovations in pharmaceutical manufacturing are central to ensuring the production of safe, effective, and high-quality medicines while meeting the demands of an evolving healthcare landscape. This session focuses on state-of-the-art approaches in pharmaceutical production, emphasizing continuous processing, process intensification, and automation. Key topics include advanced drug formulation, quality by design (QbD), real-time monitoring, digital twins for process optimization, and sustainable manufacturing practices. Discussions will cover process analytical technologies (PAT), scalable production strategies, green chemistry approaches, and regulatory considerations for continuous and flexible manufacturing systems. The session also highlights translational research bridging laboratory-scale innovations with industrial applications, fostering efficiency, product consistency, and accelerated time-to-market for novel therapeutics.

We invite pharmaceutical scientists, chemical engineers, formulation experts, process development specialists, and industry practitioners to submit one-page abstracts for presentation at the International Conference on Pharmaceutics & Innovative Drug Delivery Systems (Pharmaceutics 2027). Join us to share your research, network with global experts, and contribute to the advancement of innovative, efficient, and sustainable pharmaceutical manufacturing.

The Digital Pharmaceutics and Data-Driven Drug Development session at Pharmaceutics 2027 explores how advanced digital technologies, artificial intelligence (AI), and data analytics are transforming pharmaceutical research, formulation design, and drug delivery systems. This session highlights the integration of computational modeling, predictive algorithms, machine learning, and real-world data in accelerating drug development, optimizing formulations, and improving therapeutic outcomes.Topics include AI-assisted drug design, in silico modeling of drug release, digital twins for personalized therapeutics, predictive pharmacokinetics and pharmacodynamics, process automation, and data-driven quality control. Emphasis is placed on bridging computational insights with experimental and clinical validation to enable faster, safer, and more effective drug delivery solutions.

We invite pharmaceutical scientists, data scientists, formulation researchers, clinical researchers, and industry professionals to submit abstracts for oral or poster presentations. Join this session to explore the future of digital pharmaceutics and contribute to shaping data-driven approaches in drug development and delivery.

The Translational Research in Drug Delivery Systems session at Pharmaceutics 2027 focuses on bridging the gap between laboratory discoveries and real-world therapeutic applications. This session emphasizes strategies that accelerate the development of innovative drug delivery technologies from preclinical research to clinical implementation.Topics include formulation optimization, targeted and controlled delivery systems, nanomedicine, biologics, biosimilars, pharmacokinetics, pharmacodynamics, and patient-centered therapeutic outcomes. Case studies on successful translational pathways, regulatory considerations, scalability, and commercialization strategies will be highlighted to demonstrate practical applications.

We invite pharmaceutical scientists, clinical researchers, formulation experts, regulatory professionals, and industry practitioners to submit abstracts for oral or poster presentations. Participate in this session to share insights, explore cutting-edge translational research, and contribute to advancing drug delivery solutions that enhance therapeutic efficacy and patient care.

The Case Studies in Innovative Drug Delivery Applications session at Pharmaceutics 2027 provides a practical and evidence-based perspective on the real-world implementation of advanced drug delivery technologies. This session highlights successful applications of novel formulations, targeted therapies, nanomedicine platforms, sustained-release systems, and biologics in clinical and industrial settings.Participants will explore lessons learned from formulation development, translational research, regulatory challenges, and patient-centered therapeutic outcomes. Topics include case studies on oral, transdermal, injectable, and implantable drug delivery systems, precision-targeted therapeutics, smart and responsive delivery technologies, and scalable manufacturing strategies.

We invite pharmaceutical scientists, formulation experts, clinical researchers, and industry professionals to submit abstracts for oral or poster presentations at Pharmaceutics 2027. Join this session to share experiences, gain practical insights, and contribute to advancing innovative drug delivery solutions in healthcare and therapeutics worldwide.

The future of pharmaceutics and drug delivery is being shaped by rapid scientific innovation, digital transformation, and an increasing focus on precision and patient-centered therapies. This session explores emerging trends and next-generation technologies that are expected to redefine drug development, delivery, and clinical outcomes. Key topics include smart and responsive delivery systems, advanced nanomedicine, biologics and nucleic acid therapeutics, personalized and precision drug delivery, digital pharmaceutics, artificial intelligence–driven formulation design, and sustainable pharmaceutical manufacturing. Discussions will also address evolving regulatory landscapes, translational challenges, and opportunities for integrating interdisciplinary research into real-world healthcare solutions. Emphasis will be placed on visionary research, disruptive technologies, and strategic pathways that will shape the next decade of pharmaceutics and drug delivery science.

We invite pharmaceutical scientists, formulation and drug delivery experts, biomedical engineers, clinicians, regulatory professionals, and industry leaders to submit one-page abstracts for presentation. Join us to share insights, engage with global experts, and contribute to defining the future direction of pharmaceutics and drug delivery technologies.